Agilon Health PE Ratio 2020-2025 | AGL
Current and historical p/e ratio for Agilon Health (AGL) from 2020 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Agilon Health PE ratio as of May 09, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Agilon Health PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2025-05-09 | 2.89 | 0.00 | |
2025-03-31 | 4.33 | $-0.62 | 0.00 |
2024-12-31 | 1.90 | $-0.63 | 0.00 |
2024-09-30 | 3.93 | $-0.94 | 0.00 |
2024-06-30 | 6.54 | $-0.73 | 0.00 |
2024-03-31 | 6.10 | $-0.70 | 0.00 |
2023-12-31 | 12.55 | $-0.65 | 0.00 |
2023-09-30 | 17.76 | $-0.22 | 0.00 |
2023-06-30 | 17.34 | $-0.21 | 0.00 |
2023-03-31 | 23.75 | $-0.22 | 0.00 |
2022-12-31 | 16.14 | $-0.26 | 0.00 |
2022-09-30 | 23.42 | $-0.26 | 0.00 |
2022-06-30 | 21.83 | $-0.28 | 0.00 |
2022-03-31 | 25.35 | $-1.02 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $1.196B | $6.061B |
agilon health inc. which partners with primary care physicians to provide healthcare services. agilon health inc. is based in CA, United States. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $135.784B | 25.47 |
Elevance Health (ELV) | United States | $91.409B | 11.80 |
CVS Health (CVS) | United States | $84.718B | 10.53 |
Cencora (COR) | United States | $54.879B | 19.08 |
DiDi Global (DIDIY) | China | $20.661B | 31.36 |
Natera (NTRA) | United States | $20.542B | 0.00 |
BioMerieux (BMXMF) | France | $15.263B | 0.00 |
Solventum (SOLV) | United States | $12.150B | 12.86 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.973B | 0.00 |
Doximity (DOCS) | United States | $11.050B | 57.47 |
CochLear (CHEOY) | Australia | $10.944B | 0.00 |
ICON (ICLR) | Ireland | $10.818B | 10.06 |
Revvity (RVTY) | United States | $10.756B | 18.51 |
Viatris (VTRS) | United States | $10.400B | 3.54 |
Medpace Holdings (MEDP) | United States | $8.508B | 22.60 |
Sonic Healthcare (SKHHY) | Australia | $8.280B | 0.00 |
Avantor (AVTR) | United States | $8.191B | 11.90 |
HealthEquity (HQY) | United States | $7.819B | 38.47 |
Charles River Laboratories (CRL) | United States | $6.817B | 13.36 |
Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
Bausch + Lomb (BLCO) | Canada | $3.982B | 23.48 |
BrightSpring Health Services (BTSG) | United States | $3.976B | 36.81 |
Sotera Health (SHC) | United States | $3.727B | 21.18 |
Alignment Healthcare (ALHC) | United States | $2.991B | 0.00 |
Surgery Partners (SGRY) | United States | $2.841B | 32.59 |
Concentras Parent (CON) | United States | $2.743B | 15.85 |
Organon (OGN) | United States | $2.264B | 2.41 |
Premier (PINC) | United States | $2.106B | 14.42 |
Ardent Health Partners (ARDT) | United States | $2.073B | 8.85 |
Progyny (PGNY) | United States | $1.815B | 39.98 |
GeneDx Holdings (WGS) | United States | $1.660B | 64.99 |
GoodRx Holdings (GDRX) | United States | $1.657B | 30.86 |
PACS (PACS) | United States | $1.590B | 0.00 |
Pediatrix Medical (MD) | United States | $1.248B | 9.50 |
Teladoc Health (TDOC) | United States | $1.247B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
Establishment Labs Holdings (ESTA) | $0.978B | 0.00 | |
CareDx (CDNA) | United States | $0.855B | 13.36 |
AMN Healthcare Services Inc (AMN) | United States | $0.840B | 7.89 |
Embecta (EMBC) | United States | $0.696B | 4.71 |
QDM (QDMI) | Hong Kong, SAR China | $0.690B | 0.00 |
Nutex Health (NUTX) | United States | $0.667B | 13.08 |
Enhabit (EHAB) | United States | $0.521B | 42.83 |
Auna S.A (AUNA) | Luxembourg | $0.508B | 13.45 |
InnovAge Holding (INNV) | United States | $0.491B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
LifeMD (LFMD) | United States | $0.375B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.352B | 0.00 |
SBC Medicals (SBC) | United States | $0.345B | 0.00 |
Beauty Health (SKIN) | United States | $0.234B | 0.00 |
Oncology Institute (TOI) | United States | $0.212B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.195B | 0.00 |
DocGo (DCGO) | United States | $0.143B | 23.33 |
Basel Medical Group (BMGL) | Singapore | $0.088B | 0.00 |
So-Young (SY) | China | $0.086B | 0.00 |
Sera Prognostics (SERA) | United States | $0.084B | 0.00 |
OncoCyte (OCX) | United States | $0.082B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.076B | 0.00 |
NeueHealth (NEUE) | United States | $0.060B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
Biodesix (BDSX) | United States | $0.054B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
Pheton Holdings (PTHL) | China | $0.029B | 0.00 |
KindlyMD (KDLY) | United States | $0.023B | 0.00 |
ModivCare (MODV) | United States | $0.017B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |